Accelerated Ebola vaccine trials target Congos deadly Bundibugyo strain
Emergency Ebola vaccine trials accelerate as Congo’s rare Bundibugyo strain sparks global alarm
Three experimental vaccines targeting the rare Bundibugyo variant of the Ebola virus are now in accelerated development, as health officials warn the current outbreak in the Democratic Republic of Congo (DRC) could escalate into one of the deadliest on record. The urgency follows a rapid surge in cases and the strain’s unusual characteristics, which have triggered international concern, *El Mundo* reports .
The Bundibugyo strain, historically less common than the Zaire or Sudan variants, has spread swiftly through remote, conflict-ridden regions of eastern Congo, complicating containment efforts. Survivors describe the virus’s brutal onset: a nurse in one account began vomiting within minutes of feeling dizzy, a hallmark of Ebola’s rapid progression . The outbreak’s epicenter—a volatile area with limited healthcare infrastructure—has raised fears of undetected transmission, earning it the label of an "invisible threat" by epidemiologists.
While no specific case numbers or fatalities have been publicly confirmed, the World Health Organization (WHO) has flagged the Bundibugyo variant’s potential for higher transmissibility. The three vaccines, developed under emergency protocols, aim to target this strain directly, though clinical trials remain in early phases. Previous Ebola vaccines, such as Ervebo, were tailored to the Zaire variant and may offer limited protection against Bundibugyo.
The crisis unfolds as global health systems grapple with overlapping challenges, including cancer treatment breakthroughs presented at the American Society of Clinical Oncology (ASCO) conference in Chicago. However, experts stress that Ebola’s resurgence in Congo demands immediate resources, with one official telling *Digi24* that "every day counts" in preventing a wider catastrophe .
Background: The Bundibugyo variant was first identified in Uganda in 2007 and has since caused sporadic outbreaks, including a 2012 epidemic in Congo that killed 36% of those infected. Unlike the Zaire strain, which fueled the 2014–2016 West Africa epidemic, Bundibugyo’s lower profile has left it understudied—until now. With no approved treatments or vaccines for this variant, the current outbreak tests the limits of global preparedness.
- liberation
- independent
- digi24
- france24
- elmundo
Articles
Trei vaccinuri experimentale împotriva Ebola sunt dezvoltate în regim de urgență: „Fiecare zi contează Trei vaccinuri experimentale împotriva variantei rare Bundibugyo a virusului Ebola sunt dezvoltate în regim de urgență, pe fondul temerilor că actualul focar din Republica Democrată Congo ar putea deveni unul dintre cele mai grave din istorie.
digi24 · 5 days ago
«Cest un progrès majeur, même si on ne parle pas du tout de guérison» : contre le cancer du pancréas, un médicament donne enfin de lespoir Selon une étude présentée dimanche 31 mai au congrès international doncologie à Chicago, le daraxonrasib double la durée de survie de patients atteints dune forme métastatique de la maladie.
liberation · 5 days ago
Cáncer de hígado: una nueva estrategia terapéutica mejora la supervivencia de los pacientes inicialmente inoperables Datos del estudio presentado en el congreso de la ASCO: casi uno de cada tres pacientes sigue vivo y sin progresión de la enfermedad dos años después del tratamiento Leer
elmundo · 5 days ago
La amenaza del ébola invisible: por qué este brote en República Democrática del Congo ha hecho saltar las alarmas mundiales Un virus infrecuente, la rápida explosión de casos y un lugar remoto y hostil como epicentro del brote. En esta ocasión hay muchos ingredientes para provocar una crisis internacional de salud pública, pero los matices son importantes Leer
elmundo · 5 days ago
French doctors sound alarm over drinking water pollution Pesticides, microplastics and so-called forever chemicals: thats the cocktail of substances millions of French people are exposed to simply from drinking tap water. According to Frances National Association of Health professionals, representing private practice doctors, at least 30 percent of the population was exposed to contaminated water at least once in 2024. FRANCE 24s Environment Editor Valerie Dekimpe tells us more.
france24 · 5 days ago
Survivors tell what its like to battle Ebola: Coming out alive is an indescribable joy One nurse started feeling dizzy while he checked on patients. The vomiting started just minutes later
independent · 5 days ago
Smart drug that strips cancer cells of invisibility cloak can shrink tumours by 30, trial shows Experimental tablet produces encouraging results in patients with worlds most common forms of disease• I was getting ready to say goodbye: patients hope after smart drug successA smart drug that stops cancer cells hiding from treatment can shrink tumours by at least 30 in six of the worlds most common forms of the disease, early trial results show.While immunotherapy treatments have improved survival rates for many patients, their effectiveness can stall or fail when tumour cells hide and then spread. Continue reading...
theguardian · 5 days ago
CNAS schimbă regulile după care pacienții pot fi tratați în privat pe banii statului. Ce prevede proiectul pus în transparență Un proiect al CNAS pus în transparență schimbă regulile după care pacienții pot ajunge să fie tratați și în privat, pe banii din programul național. Mai exact, accesul pacienților la tratament în clinicile private va depinde de o formulă care măsoară dacă spitalele publice mai au sau nu loc pentru bolnavi. CNAS spune că această măsură va reduce timpii de așteptare pentru pacienți.
digi24 · 6 days ago